HER-2 / neu antigen loss and relapse of mammary carcinoma are activelyin-duced by Tcell-mediated anti-tumor inmmuneresponses .Ott PA , Hodi FS , Robert C . CTLA-4 and PD-1 / PD-L1 blockade : new immunotherapeutic modalities with durable clinical benefit i ......